TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 EUR)
Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Turnover |
2,216,891
|
1,793,541
|
174,660 |
Financial expenses |
1,021
|
1,289
|
26 |
Earnings before taxes |
435,314
|
345,174
|
31,862 |
Total assets |
3,195,762
|
2,750,048
|
258,545 |
Current assets |
2,284,881
|
2,003,544
|
184,967 |
Current liabilities |
347,209
|
278,307
|
24,298 |
Equity capital |
2,667,635
|
2,331,256
|
220,565 |
- share capital |
100
![]() |
100
|
10 |
Employees (average) |
7,908
|
7,556
|
6,782 |
Financial ratios
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Solvency |
83.5%
|
84.8%
|
85.3% |
Turnover per employee |
280
|
237
|
26 |
Profit as a percentage of turnover |
19.6%
|
19.2%
|
18.2% |
Return on assets (ROA) |
13.7%
|
12.6%
|
12.3% |
Current ratio |
658.1%
|
719.9%
|
761.2% |
Return on equity (ROE) |
16.3%
|
14.8%
|
14.4% |
Change turnover |
450,562
|
1,626,115
|
-1,377,117 |
Change turnover % |
26%
|
971%
|
-89% |
Chg. No. of employees |
352
|
774
|
613 |
Chg. No. of employees % |
5%
|
11%
|
10% |
Total value of public sale
Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.